TERT and malignant conjunctival melanoma: Fifteen patients with conjunctival melanoma developed recurrent disease and eleven patients with conjunctival melanoma developed metastatic disease, with most of the cases with metastatic disease harboring either a TERT promoter mutation or ATRX loss.